2019. Exploring the anti-breast cancer (against MCF-7 Cell Line) potentials of uracil substituted hippuric acid based 1,3,4-thiadiazole compound. International Journal of Pharmacy and Life Sciences. 10, 1 (Jan. 2019), 6013–6015.